Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.
about
Precision in Addiction Care: Does It Make a Difference?Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects.The pharmacogenetics of alcohol use disorderAlcohol and violence: neuropeptidergic modulation of monoamine systems.Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate.Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications DevelopmentGender-specific effects of comorbid depression and anxiety on the propensity to drink in negative emotional statesGlobal research challenges and opportunities for mental health and substance-use disorders.Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.Elevated Glutamate Levels in the Left Dorsolateral Prefrontal Cortex Are Associated with Higher Cravings for Alcohol.The Clinical Utility of ASRS-v1.1 for Identifying ADHD in Alcoholics Using PRISM as the Reference Standard.Strain-Dependent Effects of Acute Alcohol on Synaptic Vesicle Recycling and Post-Tetanic Potentiation in Medial Glutamate Inputs to the Mouse Basolateral Amygdala.Nociceptin Receptor as a Target to Treat Alcohol Use Disorder: Challenges in Advancing Medications Development.
P2860
Q26775801-534861A7-C721-41EC-A2BA-EC53AE3E9D17Q33746846-C850EFB7-B4B7-4071-8FFD-6DA8388C8221Q34463974-9A8571EC-DE8B-4122-9319-4BC7467D84B6Q36042637-775E14CE-FE92-4249-809F-6DC73EE65F54Q36043383-E11FFD26-9821-40D2-98BF-C14BB5B16FBDQ36145548-3EAFD70C-09D6-4559-90FD-CA549FEE8E97Q37059221-929577DE-68CC-496A-8411-AF95E73B8452Q37083434-5A787A2D-3E37-49DA-9C7E-1F30AB3EA376Q38637216-2EA89DD8-A4DC-40AE-80D1-1F936D55BD48Q39144955-090C8BD0-CC3C-42CD-BFE7-89DD2044AE54Q39579813-21673078-BEEB-4C5C-A4BB-4CF2622F02A4Q39801177-923A2169-3843-4EED-890C-FCFCC3E6144DQ46428367-F4809CB1-10C6-451A-A33D-1095016604E4Q51438275-FA8FA3A6-AFB2-4EBF-8DA4-68E68FB3B258
P2860
Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genetic markers associated wit ...... ects treated with acamprosate.
@ast
Genetic markers associated wit ...... ects treated with acamprosate.
@en
type
label
Genetic markers associated wit ...... ects treated with acamprosate.
@ast
Genetic markers associated wit ...... ects treated with acamprosate.
@en
prefLabel
Genetic markers associated wit ...... ects treated with acamprosate.
@ast
Genetic markers associated wit ...... ects treated with acamprosate.
@en
P2093
P2860
P50
P356
P1476
Genetic markers associated wit ...... ects treated with acamprosate.
@en
P2093
A A Leontovich
D K Hall-Flavin
G D Jenkins
J M Biernacka
L L Loukianova
P2860
P2888
P356
10.1038/TP.2014.103
P577
2014-10-07T00:00:00Z